Abstract
The effect of 44 different metal ions (Ag+, Al3+, AsO -2 , Au3+, Ba2+, Be2+, Bi3+, Cd2+, Ce3+, Co2+, CrO 2-4 , Cr3+, Cs+, Cu2+, Fe3+, Fe2+, Ga3+, Ge4+, Hg2+, Ir4+, La3+, Li+, Mn2+, Mo6+, Ni2+, Os4+, Pb2+, Pt4+, Rb+, Rh3+, Sb5+, SeO 2-4 , SeO 2-3 , Sn2+, Sr2+, Th4+, Tl+, UO2/2+, VO3/-, VO2+, WO 2-4 , Y3+, Zn2+, and Zr4+) on the activity of the reverse transcriptase (RT) of the human immunodeficiency virus (HIV-1) was investigated in vitro. For this study, the RT activity assay was carried out by means of an enzyme-linked immunosorbent assay (ELISA) kit, using the template/primer hybrid poly(A) · oligo(dT)15, which required some modifications: (1) possible interfering metal chelators (such as EDTA) in the original lysis buffer were avoided, and a new buffer (50 mM Tris-NO3, pH 7.8) was used throughout; (2) an amount of 2 ng of RT per well was considered to be optimal after checking the linearity of the reaction with increasing amounts of enzyme; (3) an incubation temperature of 37‡C and an incubation time of 1 h were chosen after preliminary studies in a wide range of temperature and time. At an incubation temperature ≥40‡C, there was a dramatic loss of enzymatic activity. In addition, when RT alone was preincubated for 1 h at 5‡C, 25‡C, and 37‡C, there was a large (83%) loss of activity at 37‡C as compared to that at 5‡C. These results are indicative of enzyme thermolability, which is higher in the absence of substrates. The effect of metal ions on RT activity was tested using two different metal salt concentrations (10-4 M and 10-5 M). Under such experimental conditions, the presence of five metal ions (Pt4+, Ag+, Rh3+, Zn2+, and Hg2+) decreased the RT activity in a dose-response fashion. The observed order of effectiveness with respect to inhibition was Pt4+ > Ag+ > Rh3+ > Zn2+ = Hg2+. Estimated mean inhibitory concentrations (IC50) were 7.8 ΜM for (NH4)2PtCl6, 14.1ΜM for AgNO3, 46.8ΜM for RhCl3, 53.7ΜM for Zn(SO)4, and 56.2 ΜM for Hg(NO3)2. Because these data are of the same order of magnitude as the corresponding values related to other RT inhibitors used in anti-AIDS therapy, metal compounds or their derivatives could give an interesting contribution in the development of new RT inhibitors for clinical use.
Similar content being viewed by others
References
S. P. Goff, Retroviral reverse transcriptase synthesis structure and function,J. AIDS 3, 817–831 (1990).
E. Gilboa, S. W. Mitra, S. Goff, and D. Baltimore, A detailed model of reverse transcription and test of crucial aspects,Cell 18, 93–100 (1979).
F. di Marzo Veronese, T. D. Copeland, A. L. DeVico, R. Rahman, S. Oroszlan, R. C. Gallo, et al., Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV,Science 231, 1289–1291 (1986).
A. G. Filler and A. M. L. Lever, Effects of cations substitutions on reverse transcriptase and human immunodeficiency virus production.AIDS Res. Hum. Retrovirus 13, 291–299 (1997).
J. F. Davies, Z. Hostomska, Z. Hostomsky, S. R. Jordan, and D. A. Matthews, Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase,Science 252, 88–95 (1991).
R. F. Doolittle, D. F. Feng, M. S. Johnson, and M. A. McClure, Origins and evolutionary relationships of retroviruses,Quart. Rev. Biol. 64, 1–30 (1989).
L. A. Kohlstaedt, J. Wang, J. M. Friedman, and P. A. Rice, Crystal structure at 3.5 å resolution of HIV-1 reverse transcriptase complexed with an inhibitor,Science 256, 1783–1790 (1992).
D. S. Auld, H. Kawaguchi, D. M. Livingson, and B. L. Vallee, Zinc reverse transcriptase from mammalian RNA type C viruses,Biochem. Biophys. Res. Commun. 62, 296–302 (1975).
M. J. Abrams and A. M. Barry, Metal compounds in therapy and diagnosis,Science 261, 725–730 (1993).
A. S. Mildvam and L. A. Loeb, The role of metal ions in the mechanism of DNA and RNA polymerases,CRC Crit. Rev. Biochem. 61, 219–244 (1979).
C. L. Hill, M. S. Weeks, and R. F. Schinazi, Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates,J. Med. Chem. 33, 2767–2772 (1990).
T. C. Woon, R. I. Brinkworth, and D. P. Fairlie, Inhibition of HIV-1 proteinase by metal ions,Int. J. Biochem. 24, 911–914 (1992).
J. A. V. Coates, N. Cammack, H. J. Jenkinson, I. M. Mutton, B. A. Pearson, R. Storer, et al., The separated enantiomer of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vivo,Antimicrob. Agents Chemotherap. 36, 202–205 (1992).
D. L. Romero, M. Busso, C. K. Tan, F. Reusser, J. R. Palmer, S. M. Poppe, et al., Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication,Proc. Natl. Acad. Sci. USA 88, 8806–8810 (1991).
M. E. Goldman, J. H. Nunberg, J. A. O’Brien, J. C. Quintero, W. A. Schleif, K. F. Freund, et al., Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity,Proc Natl Acad Sci USA 88, 6863–6867 (1991).
S. Vella, Update on a proteinase inhibitor,AIDS 8(Suppl.3), S25-S29 (1994).
D. D. Richman, HIV drug resistance,Annu. Rev. Pharmacol. Toxicol. 32, 149–164 (1993).
D. D. Richman, J. C. Gatelli, J. Grimes, A. Tsiatis, and T. Gingeras, Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the PCR,J. Infect. Dis. 164, 1075–1081 (1991).
L. Sillén and A. Martell,Stability Constants of Metal-Ion Complexes, The Chemical Society, Burlington House, London (1964).
D. Crans, R. Bunch, and L. Theisen, Interaction of trace levels of vanadium(IV) and vanadium(V) in biological systems,J. Am. Chem. Soc. 111, 7595–7607 (1989).
M. A. Serra, V. Barassi, C. Canavese, and E. Sabbioni, Aluminium effect on the activity of superoxide dismutase and of other antioxygenic enzymes in vitro,Biol. Trace Element Res. 31, 79–96 (1991).
G. L. Rowley, Q. Ma, I. C. Bathurst, P. J. Barr, and G. L. Kenyon, Stabilization and activation of recombinant human immunodeficiency virus-1 reverse transcriptase-p66,Biochem. Biophys. Res. Commun. 167, 673–679 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabbioni, E., Blanch, N., Baricevic, K. et al. Effects of trace metal compounds on HIV-1 reverse transcriptase. Biol Trace Elem Res 68, 107–119 (1999). https://doi.org/10.1007/BF02784400
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784400